Form 4 for MRK Merck & Co.
Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-03 · accession 0001127602-22-013210 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-04 | 2022-05-03 | MRK | Garay Arpa | SVP Human Health Gbl Mktg | M - OptEx | $87.65 | +773 | 1,682 | +85% | +$67.8K |
| D | 2022-05-04 | 2022-05-03 | MRK | Garay Arpa | SVP Human Health Gbl Mktg | F - Tax | $87.65 | -221 | 1,461 | -13% | -$19.4K |
| D | 2022-05-04 | 2022-05-03 | MRK | Garay Arpa | SVP Human Health Gbl Mktg | M - OptEx | $0.00 | -773 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-03 | M | A | 773 | $87.65 | 1,682 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-03 | F | D | 221 | $87.65 | 1,461 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 3 | Derivative | Restricted Stock Unit | 2022-05-03 | M | D | 773 | $0.00 | 0 | D | — · 2020-05-03 to 2022-05-03 | 773 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) The restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installment on 5/3/2020, 5/3/2021 and 5/3/2022. |